Rethinking the pharma R&D lifecycle with AI in mind
Drug Discovery World
AUGUST 7, 2024
Within the next five to 10 years, AI will fundamentally change the way drugs are designed, with the potential to produce an order of magnitude for more high-quality candidates against a broad range of new diseases. Pharma R&D has been heading in the wrong direction, becoming progressively less efficient over the last few decades.
173 
Let's personalize your content